Solesence, Inc. Common Stock
SLSN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.33 | 0.01 | -3.95 | 0.64 |
| FCF Yield | -1.29% | -0.21% | -5.02% | -0.24% |
| EV / EBITDA | -452.82 | 97.38 | 341.18 | 36,943.24 |
| Quality | ||||
| ROIC | -1.83% | 3.72% | 0.67% | -0.73% |
| Gross Margin | 23.09% | 28.87% | 23.12% | 22.01% |
| Cash Conversion Ratio | 2.24 | -0.25 | -90.26 | -3.92 |
| Growth | ||||
| Revenue 3-Year CAGR | 3,960,938.40% | 4,008,568.70% | 3,850,740.32% | 3,740,695.20% |
| Free Cash Flow Growth | -347.86% | 90.94% | -1,687.38% | -114.43% |
| Safety | ||||
| Net Debt / EBITDA | -44.52 | 6.59 | 43.03 | 2,777.60 |
| Interest Coverage | -2.30 | 21.95 | 1.45 | -2.06 |
| Efficiency | ||||
| Inventory Turnover | 0.59 | 0.73 | 0.51 | 0.48 |
| Cash Conversion Cycle | 172.44 | 129.27 | 157.92 | 122.81 |